首页>
中文期刊>
《海南医科大学学报(英文版)》
>Effects of concurrent chemoradiotherapy on serum tumor markers, MMP-9, VEGF and inflammatory factors in patients with endometrial carcinoma after operation
Effects of concurrent chemoradiotherapy on serum tumor markers, MMP-9, VEGF and inflammatory factors in patients with endometrial carcinoma after operation
Objective:To investigate effects of concurrent chemoradiotherapy on serum tumor markers, vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9) and inflammatory factors in patients with endometrial carcinoma after operation.Methods: A total of 86 patients with endometrial carcinoma treated by surgery were selected as objects of study, according to random data table they were divided into control group (n=42) and observation group (n=44), patients of two groups were all underwent hysterectomy and bilateral adnexectomy treatment, on this basis, the control group was given radiotherapy treatment, observation group patients received concurrent chemotherapy treatment, the levels of serum tumor markers, VEGF, MMP-9 and inflammatory factor of the two groups before and after treatment were compared.Results: Before treatment, there was no significant difference in CA-125, HE4, VEGF, MMP-9, TNF-α, CRP and IL-6 levels between the observation group and the control group; After treatment, the levels of CA-125, HE4, VEGF, MMP-9, TNF-α, CRP and IL-6 in the two groups were significantly lower than those in the group before treatment, and the difference was statistically significant; After treatment, the levels of CA-125, HE4, VEGF, MMP-9, TNF-α, CRP and IL-6 in the observation group were significantly lower than those in the control group, the difference was statistically significant.Conclusion:The concurrent radiotherapy and chemotherapy can effectively reduce the levels of serum tumor markers, VEGF and MMP-9, and effectively decrease the inflammatory stress response in patients with endometrial carcinoma after operation, with critical clinical value.
展开▼